Bill > HR7006

This bill, the Improving the Nation's Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act (INSPECTIONS Act), aims to improve the inspection of foreign drug manufacturing establishments by the Food and Drug Administration (FDA). Key provisions include: expanding the risk factors the FDA can consider when determining inspection priorities, allowing the FDA to use records from previous inspections to satisfy requirements for future inspections, and requiring the FDA to periodically review and report on agreements with foreign governments for mutual recognition of inspections. The bill also directs the Government Accountability Office (GAO) to report on the FDA's use of alternative tools, such as remote inspections, to facilitate inspections of foreign facilities, and how the agency is addressing workforce challenges to carry out its inspection activities.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/7006/all-info